dm+d
404845006
Refrigerated Storage
FaslodexAstraZeneca
AstraZeneca
Faslodex
250 mg solution for injection
In the event of an inadvertent temperature excursion the following data may be used:
The product may be exposed to temperatures up to a maximum 25°C for a cumulative period of 28 days, without any effect on stability.
Exposure to temperatures below 2°C (up to -20°C) will also not affect the product’s stability.
Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk
No
Yes
25 March 2021
London MI Service
Lactation Safety Information
May interfere with lactation
No published evidence of safety
Theoretical risk of impaired development of infant (see summary)
16 September 2020